Alcon: market hails reassuring outlook

(CercleFinance.com) - On Wednesday, eye care products manufacturer Alcon reported annual results that were broadly in line with expectations, while investors were reassured by the prospect of accelerated growth and improved margins in 2025.


This morning, the Geneva-based group reported Q4 sales of $2.5bn, up 6% as reported and at constant exchange rates.

Its core operating margin also improved from 18.9% to 20.1%.

FY 2024 sales rose by 5% to $9.8bn, including 6% growth at constant exchange rates.

Its operating margin was 20.6%, compared with 19.7% in 2023.

For 2025, Alcon is targeting sales of $10.2bn to $10.4bn, representing growth of 6% to 8% at constant exchange rates, thanks to the launch of new products.

Its operating margin is also expected to rise, to between 21% and 22% this year.

Following this publication, Alcon shares were up almost 6% late on Wednesday morning, the biggest winner in the SMI index.


Copyright (c) 2025 CercleFinance.com. All rights reserved.